<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News for Canada-based  companies .</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 08 Feb 2012 03:56:05 +0100</pubDate>
		<lastBuildDate>Wed, 08 Feb 2012 03:56:05 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Aptalis Pharma Announces FDA Approval of NDA for Oral Powder Formulation of Viread(R), Co-Developed With Gilead Sciences, Inc.</title>
			<link>http://www.lifescience-online.com/Aptalis_Pharma_Announces_FDA_Approval_of_NDA_for_O,30672.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Anti-Infective</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/aptalis_pharma,360.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Aptalis Pharma</u></font></a><br /><a href='http://www.lifescience-online.com/gilead_sciences,692.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GILEAD SCIENCES INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/TENOFOVIR_DISOPROXIL_FUMARATE,3391.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>TENOFOVIR DISOPROXIL FUMARATE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 17 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Cynapsus Announces Successful Human Volunteer Pilot Proof-of-Concept Results for APL-130277, a Sublingual Thin Film Strip Drug Candidate for Parkinson&#039;s</title>
			<link>http://www.lifescience-online.com/Cynapsus_Announces_Successful_Human_Volunteer_Pilo,30581.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/cynapsus_therapeutics,9720.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CYNAPSUS THERAPEUTICS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/APL-130277,24985.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>APL-130277</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 09 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics</title>
			<link>http://www.lifescience-online.com/Xenon_to_Collaborate_with_Genentech_on_Discovery_o,30628.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/roche_holding,1071.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ROCHE HOLDING LTD</u></font></a><br /><a href='http://www.lifescience-online.com/xenon_pharmaceuticals,7058.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>XENON PHARMACEUTICALS INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 08 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>AEterna Zentaris (AEZS) Partner, Yakult Honsha, Initiates Phase 1/2 Trial with Perifosine in Colorectal Cancer in Japan</title>
			<link>http://www.lifescience-online.com/AEterna_Zentaris__AEZS__Partner__Yakult_Honsha__In,30410.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/aeterna_zentaris,273.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>AETERNA ZENTARIS INC</u></font></a><br /><a href='http://www.lifescience-online.com/yakult_honsha_kk,4702.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>YAKULT HONSHA KK</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/PERIFOSINE,839.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>PERIFOSINE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 02 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Generex Biotechnology Corporation (GNBT) Subsidiary Antigen Express, Inc. (GNBT) Provides Update on AE37 Cancer Vaccine&#039;s Clinical  and  Regulatory Strategy</title>
			<link>http://www.lifescience-online.com/Generex_Biotechnology_Corporation__GNBT__Subsidiar,30401.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/generex_biotechnology,678.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GENEREX BIOTECHNOLOGY CORP</u></font></a><br /><a href='http://www.lifescience-online.com/antigen_express,5008.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ANTIGEN EXPRESS</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/II-KEY/HER-2/NEU,21650.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>II-KEY/HER-2/NEU</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 02 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Isotechnika Enters Into Development and Commercialization License Agreement With Vifor Pharma</title>
			<link>http://www.lifescience-online.com/Isotechnika_Enters_Into_Development_and_Commercial,30412.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Immunomodulation</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/isotechnika,5909.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ISOTECHNIKA</u></font></a><br /><a href='http://www.lifescience-online.com/vifor_pharma,11910.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Vifor Pharma Ltd</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/VOCLOSPORIN,4178.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>VOCLOSPORIN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 02 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>APRICUS BIOSCIENCES AND STELLAR PHARMACEUTICALS ANNOUNCE EXCLUSIVE LICENSE AGREEMENT IN CANADA FOR THE COMMERCIALIZATION OF MYCOVA(TM) FOR ONYCHOMYCOSIS</title>
			<link>http://www.lifescience-online.com/APRICUS_BIOSCIENCES_AND_STELLAR_PHARMACEUTICALS_AN,30531.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Anti-Infective</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/apricus_biosciences,949.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>APRICUS BIOSCIENCES INC</u></font></a><br /><a href='http://www.lifescience-online.com/stellar_pharmaceuticals,9791.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>STELLAR PHARMACEUTICALS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/NM-100060,25213.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NM-100060</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 02 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Alexion to Acquire Enobia Pharma Corp. and First Potential Treatment for Patients with Hypophosphatasia (HPP)</title>
			<link>http://www.lifescience-online.com/Alexion_to_Acquire_Enobia_Pharma_Corp__and_First_P,30523.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/3/1.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Changes and Acquisitions</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/alexion_pharmaceuticals,281.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ALEXION PHARMACEUTICALS INC</u></font></a><br /><a href='http://www.lifescience-online.com/enobia_pharma,5601.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Enobia Pharma Inc</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 27 Dec 2011 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>
